Chemotherapy with cisplatin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow Esophagogastric Junction Hepatic Artery

Organisms1

Diseases83

Lung Neoplasms Ovarian Neoplasms Breast Neoplasms Carcinoma, Non-Small-Cell Lung Vomiting Neoplasm Recurrence, Local Neoplasms Testicular Neoplasms Nausea Adenocarcinoma Neutropenia Carcinoma, Squamous Cell Leukopenia Head and Neck Neoplasms Neoplasms, Germ Cell and Embryonal Neoplasm Metastasis Stomach Neoplasms Germinoma Osteosarcoma Carcinoma Peritoneal Neoplasms Thrombocytopenia Bone Neoplasms Lymphoma, Non-Hodgkin Liver Neoplasms Hodgkin Disease Brain Neoplasms Colorectal Neoplasms Esophageal Neoplasms Disease Progression Mesothelioma Lymphatic Metastasis Hematologic Diseases Pleural Neoplasms Recurrence Nasopharyngeal Neoplasms Retroperitoneal Neoplasms Urinary Bladder Neoplasms Seminoma Urologic Neoplasms Carcinoma, Transitional Cell Stomatitis Lymphoma Sarcoma Mediastinal Neoplasms Pancreatic Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Dysgerminoma Biliary Tract Neoplasms Leukemia, Myeloid, Acute Colonic Neoplasms Mucositis Neoplasms, Glandular and Epithelial Neoplasm, Residual Uterine Cervical Neoplasms Carcinoma, Small Cell Small Cell Lung Carcinoma Vomiting, Anticipatory Hepatoblastoma Medulloblastoma Melanoma Peripheral Nervous System Diseases Alopecia Lymphoma, Large B-Cell, Diffuse Muscle Neoplasms Central Nervous System Neoplasms Neoplasms, Second Primary Bone Marrow Diseases Glioma Neuroblastoma Soft Tissue Neoplasms Neoplasms, Unknown Primary Anemia Neoplasm Invasiveness Cerebellar Neoplasms Fatigue Rectal Neoplasms Multiple Myeloma Glioblastoma Leukemia, Myeloid Cystadenocarcinoma, Serous Abdominal Neoplasms Leukemia

Chemicals and Drugs76

Cisplatin Antineoplastic Agents Doxorubicin Etoposide Cyclophosphamide Vinblastine Paclitaxel Platinum Carboplatin Deoxycytidine Ifosfamide Taxoids Methotrexate Bleomycin Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic Camptothecin Mitomycin Antineoplastic Agents, Alkylating Tegafur Vindesine Antiemetics Cytarabine Organoplatinum Compounds Anthracyclines Platinum Compounds Carmustine Oxonic Acid DNA Adducts Dacarbazine Antibiotics, Antineoplastic Granulocyte Colony-Stimulating Factor Fluorouracil Lomustine Melphalan Antibodies, Monoclonal, Humanized Tumor Markers, Biological Granisetron Ondansetron Thiotepa Mitoxantrone Mitomycins Tumor Suppressor Protein p53 Daunorubicin Antibodies, Monoclonal Bridged Compounds Guanine Mesna Amifostine Drug Combinations Dexamethasone P-Glycoprotein Radiation-Sensitizing Agents Receptor, erbB-2 Metoclopramide Nimustine Floxuridine Proto-Oncogene Proteins c-bcl-2 Endonucleases Quinazolines Prednisolone Antibodies, Monoclonal, Murine-Derived Receptors, Estrogen Tamoxifen Recombinant Proteins Glutamates Neoplasm Proteins DNA, Neoplasm Angiogenesis Inhibitors Biomarkers, Pharmacological Teniposide DNA-Binding Proteins Prochlorperazine Epirubicin Altretamine Thioguanine

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Drug Administration Schedule Disease-Free Survival Survival Analysis Neoadjuvant Therapy Neoplasm Staging Survival Rate Prognosis Induction Chemotherapy Infusions, Intravenous Salvage Therapy Follow-Up Studies Radiotherapy, Adjuvant Drug Screening Assays, Antitumor Chemotherapy, Cancer, Regional Perfusion Radiotherapy Infusions, Intra-Arterial Kaplan-Meier Estimate Prospective Studies Transplantation, Autologous Radiotherapy Dosage Clinical Trials as Topic Drug Evaluation Feasibility Studies Palliative Care Hyperthermia, Induced Drug Therapy Hematopoietic Stem Cell Transplantation Maximum Tolerated Dose Randomized Controlled Trials as Topic Xenograft Model Antitumor Assays Actuarial Analysis Dose Fractionation Cranial Irradiation Clinical Trials, Phase III as Topic Multivariate Analysis Proportional Hazards Models Infusions, Parenteral Pilot Projects Immunohistochemistry Clinical Trials, Phase II as Topic Chemoradiotherapy Administration, Oral Maintenance Chemotherapy Bone Marrow Transplantation Treatment Failure Random Allocation Fatal Outcome Cystectomy Tomography, X-Ray Computed Predictive Value of Tests Chemoradiotherapy, Adjuvant Neoplasm Transplantation Tumor Burden Inhibitory Concentration 50 Antineoplastic Protocols Mastectomy Risk Factors Consolidation Chemotherapy Hematopoietic Stem Cell Mobilization Radiotherapy, High-Energy Injections, Intravenous Drug Delivery Systems Gastrectomy Preoperative Care Lymph Node Excision

Phenomena and Processes16

Drug Resistance, Neoplasm Dose-Response Relationship, Drug Apoptosis Time Factors Drug Synergism DNA Adducts Cell Survival DNA Damage Gene Expression Regulation, Neoplastic Maximum Tolerated Dose Drug Resistance DNA Repair Drug Resistance, Multiple Cell Proliferation Inhibitory Concentration 50 Cell Cycle

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Health Care25

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Kaplan-Meier Estimate Prospective Studies Clinical Trials as Topic Feasibility Studies Palliative Care Randomized Controlled Trials as Topic Actuarial Analysis Clinical Trials, Phase III as Topic Multivariate Analysis Proportional Hazards Models Pilot Projects Clinical Trials, Phase II as Topic Treatment Failure Random Allocation Fatal Outcome Predictive Value of Tests Antineoplastic Protocols Risk Factors Age Factors Preoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Cisplatin Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Antineoplastic Agents Combined Modality Therapy Doxorubicin Treatment Outcome Etoposide Cyclophosphamide Drug Administration Schedule Lung Neoplasms Disease-Free Survival Drug Resistance, Neoplasm Survival Analysis Neoadjuvant Therapy Vinblastine Paclitaxel Platinum Neoplasm Staging Carboplatin Survival Rate Deoxycytidine Ovarian Neoplasms Ifosfamide Taxoids Breast Neoplasms Prognosis Methotrexate Carcinoma, Non-Small-Cell Lung Vomiting Neoplasm Recurrence, Local Induction Chemotherapy Bleomycin Neoplasms Testicular Neoplasms Cell Line, Tumor Nausea Antimetabolites, Antineoplastic Adenocarcinoma Neutropenia Carcinoma, Squamous Cell Leukopenia Infusions, Intravenous Head and Neck Neoplasms Antineoplastic Agents, Phytogenic Camptothecin Dose-Response Relationship, Drug Mitomycin Antineoplastic Agents, Alkylating Salvage Therapy Neoplasms, Germ Cell and Embryonal Follow-Up Studies Neoplasm Metastasis Stomach Neoplasms Tegafur Apoptosis Radiotherapy, Adjuvant Drug Screening Assays, Antitumor Time Factors Vindesine Antiemetics Cytarabine Chemotherapy, Cancer, Regional Perfusion Germinoma Organoplatinum Compounds Anthracyclines Platinum Compounds Drug Synergism Carmustine Oxonic Acid Osteosarcoma DNA Adducts Radiotherapy Infusions, Intra-Arterial Dacarbazine Antibiotics, Antineoplastic Kaplan-Meier Estimate Carcinoma Granulocyte Colony-Stimulating Factor Fluorouracil Prospective Studies Peritoneal Neoplasms Transplantation, Autologous Radiotherapy Dosage Thrombocytopenia Bone Neoplasms Tumor Cells, Cultured Clinical Trials as Topic Lymphoma, Non-Hodgkin Liver Neoplasms Hodgkin Disease Cell Survival Brain Neoplasms Colorectal Neoplasms Lomustine Melphalan Drug Evaluation Esophageal Neoplasms Disease Progression Mesothelioma

No FAQ available that match "chemotherapy with cisplatin"